Abstract
Patients with painful diabetic polyneuropathy (PDN) commonly report neuropathic pain symptoms. Partanen and colleagues found that amongst 132 patients newly diagnosed with non-insulin-dependent diabetes mellitus (NIDDM), 7–13 % reported pain and paraesthesia [1]. In the same patient group 10 years post-diagnosis, 20 % reported pain and 33 % reported paraesthesia. In a study involving 2,610 NIDDM patients, Sorensen and colleagues found that painful neuropathy was present in 11.4 % of those who had a vibration perception threshold ≥30 V and in 3.3 % of those who had a vibration perception threshold <30 [2]. A cross-sectional study conducted in the UK reported that 26.4 % of 269 NIDDM patients with PDN experienced some degree of pain, and amongst those classified as having no neuropathy according to the Toronto Clinical Neuropathy Scoring System, 7.4 % reported pain [3].
Keywords
- Pain Reduction
- Spinal Cord Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Sodium Valproate
- Isosorbide Dinitrate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Partanen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Eng J Med. 1995;333(2):89–94.
Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic control. Diabetes Res Clin Pract. 2002;57:45–51.
Davies M, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–22.
Wong MC, Chung WY, Wong KS. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. Br Med J. 2007;335:87–96.
Sindrup SH, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized double-blind, controlled trial. Pain. 1999;83:85–90.
Sindrup SH, et al. The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolites levels. Clin Pharmacol Ther. 1999;66:636–41.
Freynhagen R, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254–63.
Moon DE, et al. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Clin Ther. 2010;32(14):2370–85.
Guan Y, et al. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Clin Ther. 2011;33(2):159–66.
Ertas M, et al. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain. 1998;75:257–9.
Erdemoglu AK, Varlibas A. Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy. Neurol India. 2006;54(2):173–7.
Stracke H, et al. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care. 1992;15:1550–5.
Gorson KC, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry. 1999;66(2):251–2.
Vinik AI, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain. 2007;128:169–79.
Kadiroglu AK, et al. The effect of venlafaxine HCL on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications. 2008;22:241–5.
Gilron I, et al. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrolment randomized withdrawal placebo-controlled trial. Clin J Pain. 2011;27:185–93.
Beydoun S, et al. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand. 2007;115:284–588.
Raskin J, et al. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med. 2006;7(5):373–85.
Harati Y, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000;14(2):65–70.
Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74.
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.
Benbow SJ, Wallymahmed ME, Macfarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med. 1998;91(11):733–7.
Max MB, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991;45:3–9.
Sindrup SH, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547–52.
Kvinesdal B, et al. Imipramine treatment of painful diabetic neuropathy. JAMA. 1984;251:1727–30.
Max MB, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37:589–96.
Goldstein DJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116:109–18.
Raskin J, D’Souza DN, Wernicke JF. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6(5):346–56.
Rowbotham MC, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110:697–706.
Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 1992;13:107–12.
Ambrósio AF, et al. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res. 2002;27(1/2):121–30.
Errington AC, et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2007;73(1):157–69.
Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 1999;288:1026–30.
Tremont-Lukats IW, Megett C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2000;60(5):1029–52.
Rose MA, Kam PCA. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57(5):451–62.
Field MJ, et al. Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A. 2006;103(46):17537–42.
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregablin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007;73(2):137–50.
Lee WS, et al. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and Trigeminal stimulation. Br J Pharmacol. 1995;116(1):1661–7.
Cutrer FM, Limmroth VL, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia. 1997;17(2):93–100.
Kochar DK, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes—a randomized placebo controlled study. Acta Neurol Scand. 2002;106:248–52.
Kochar DK, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. Q J Med. 2004;97:33–8.
Backonja M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280(21):1831–6.
Eisenberg E, et al. Lamotrigine reduces painful diabetic neuropathy. A randomized, controlled study. Neurology. 2001;57:505–9.
Rull JA, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): double blind crossover trial. Diabetologia. 1969;5:215–8.
Lesser H, et al. Pregabalin relieves symptoms of painful diabetic neuropathy. A randomised controlled trial. Neurology. 2004;63:2104–10.
Rosenstock J, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628–38.
Richter RW, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomised, placebo-controlled trial. J Pain. 2005;6(4):253–60.
Arezzo JC, et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008;8:33.
Satoh J, et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med. 2011;28:109–16.
Rauck RL, et al. Lascosamide in painful diabetic peripheral neuropathy. Clin J Pain. 2007;23:150–8.
Shaibani A, et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain. 2009;10(8):818–28.
Wymer JP, et al. Efficacy and safety of lacosamide in diabetic neuropathy pain. An 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain. 2009;25:376–85.
Ziegler A, et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care. 2010;33:839–41.
Dogra S, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain. 2005;9:543–54.
Beydoun A, et al. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006;113:395–404.
Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy. Neurology. 2003;60:927–34.
Watson CPN, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71–8.
Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol. 1993;108(3):806–11.
Raffa RB, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an “atypical” opioid analgesic. J Pharmacol Exp Ther. 1992;260(1):275–85.
Reimann W, Hennies HH. Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol. Biochem Pharmacol. 1994;47(12):2289–93.
Harati Y, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842–6.
Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389–400.
Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1988;2:9–11.
Oskarsson P, Ljunggren JG, Lins PE. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care. 1997;20:1594–7.
Wright JM, Oki JC, Graves III L. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother. 1997;31:29–34.
Nelson KA, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48:1212–8.
Selvarajah D, et al. Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care. 2010;33: 128–30.
Yuen KCJ, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosordibe dinitrate spray. A double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25:1699–703.
Agrawal RP, et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract. 2007;77:161–7.
Agrawal RP, et al. Management of diabetic neuroapthy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract. 2009;83:371–8.
Capsaicin study group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med. 1991;151:2225–9.
Otto M, et al. Pain phenomena and possible mechanism in patients with painful polyneuropathy. Pain. 2003;101:187–92.
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.
Kane K, Taub A. A history of local electrical analgesia. Pain. 1975;1:125–38.
Melzack R, Wall PD. The challenge of pain. London: Penguin Books Ltd.; 1996.
Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(3758):108.
Jones L, Johnson MI. Transcutaneous electrical nerve stimulation. Contin Educ Anaesth Crit Care Pain. 2009;9(4):130–5.
Hansson P, Lundeberg T. Transcutaneous electrical nerve stimulation, vibration and acupuncture as pain-relieving measures. In: Wall PD, Melzack R, editors. Textbook of pain. London: Churchill Livingstone; 1999.
Jin DM, et al. Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2010;89:10–5.
Gossrau G, et al. Microcurrent transcutaneous electric nerve stimulation in painful diabetic neuropathy: a randomized placebo-controlled study. Pain Med. 2011;12:953–60.
Reichstein L, et al. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia. 2005;48:824–8.
Bosi E, et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005;48:817–23.
de Vos CC, et al. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. J Diabetes Complications. 2009;23:40–5.
Abuaisha BB, Costanzi JB, Boulton AMJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998;39:115–21.
Swislocki A, et al. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage. 2010;39(1):88–99.
Weintraub MI, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind placebo-controlled trial. Arch Phys Med Rehabil. 2003;84:736–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wong, Mc., Chung, J.W.Y. (2013). Impact of Treatments for Painful Diabetic Polyneuropathies on Patients. In: Lawson, E., Backonja, M. (eds) Painful Diabetic Polyneuropathy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6299-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6299-6_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6298-9
Online ISBN: 978-1-4614-6299-6
eBook Packages: MedicineMedicine (R0)